Omeros (OMER) News Today $3.17 +0.01 (+0.32%) Closing price 05/27/2025 04:00 PM EasternExtended Trading$3.20 +0.02 (+0.79%) As of 05:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OMER Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Omeros: On The Brink As It Awaits Its Fall PDUFA For A Potential BlockbusterMay 27 at 11:36 PM | seekingalpha.comOmeros: On The Brink As It Awaits Its Fall PDUFA For A Potential BlockbusterMay 27 at 11:32 PM | seekingalpha.comOmeros Co. (NASDAQ:OMER) Given Average Recommendation of "Moderate Buy" by AnalystsShares of Omeros Co. (NASDAQ:OMER - Get Free Report) have received a consensus rating of "Moderate Buy" from the five analysts that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issMay 24, 2025 | marketbeat.comOmeros FY2025 EPS Estimate Raised by Cantor FitzgeraldOmeros Co. (NASDAQ:OMER - Free Report) - Equities researchers at Cantor Fitzgerald boosted their FY2025 earnings estimates for Omeros in a report released on Monday, May 19th. Cantor Fitzgerald analyst O. Brayer now expects that the biopharmaceutical company will earn ($2.04) per share for the yeMay 23, 2025 | marketbeat.comFY2025 EPS Estimates for Omeros Lifted by Cantor FitzgeraldMay 23, 2025 | americanbankingnews.comOmeros Co. (NASDAQ:OMER) Receives Consensus Rating of "Moderate Buy" from AnalystsMay 22, 2025 | americanbankingnews.comJacobs Levy Equity Management Inc. Makes New $1.03 Million Investment in Omeros Co. (NASDAQ:OMER)Jacobs Levy Equity Management Inc. bought a new position in shares of Omeros Co. (NASDAQ:OMER - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 104,538 shares of the biopharmaceutical company's stock, valuedMay 19, 2025 | marketbeat.comOmeros Corporation (NASDAQ:OMER) Q1 2025 Earnings Call TranscriptMay 17, 2025 | insidermonkey.comQ1 2025 Omeros Corp Earnings CallMay 17, 2025 | finance.yahoo.comNomura Holdings Inc. Raises Holdings in Omeros Co. (NASDAQ:OMER)Nomura Holdings Inc. boosted its stake in shares of Omeros Co. (NASDAQ:OMER - Free Report) by 136.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 747,281 shares of the biopharmaceutical company's stock after acquiring an aMay 17, 2025 | marketbeat.comOmeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab ...May 16, 2025 | finance.yahoo.comOmeros Stock Falls to 52-Week Low on 1Q Results, Company Pauses TrialMay 16, 2025 | marketwatch.comOmeros (OMER) Projected to Post Earnings on ThursdayOmeros (NASDAQ:OMER) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 15. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-15-omeros-co-stock/)May 16, 2025 | marketbeat.comQ1 2025 Omeros Corp Earnings Call TranscriptMay 16, 2025 | gurufocus.comOmeros Corporation (OMER) Q1 2025 Earnings Conference Call TranscriptMay 15, 2025 | seekingalpha.comOmeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptanceMay 15, 2025 | msn.comOmeros Corporation Reports First Quarter 2025 Financial ResultsMay 15, 2025 | businesswire.com7OMER : Examining the Future: Omeros's Earnings OutlookMay 15, 2025 | benzinga.comOmeros Q1 2025 Earnings PreviewMay 15, 2025 | msn.comOmeros (NASDAQ:OMER) Given Buy Rating at D. Boral CapitalD. Boral Capital reaffirmed a "buy" rating and set a $36.00 target price on shares of Omeros in a research note on Tuesday.May 15, 2025 | marketbeat.comOmeros (OMER) to Release Q1 Earnings ResultsMay 14, 2025 | gurufocus.comOmeros restructures debt with new convertible notesMay 13, 2025 | investing.comOmeros Corporation to Announce First Quarter Financial Results on May 15, 2025May 12, 2025 | gurufocus.comOmeros Corporation to Announce First Quarter Financial Results on May 15, 2025 | OMER Stock NewsMay 12, 2025 | gurufocus.comOmeros Corporation to Announce First Quarter Financial Results on May 15, 2025May 12, 2025 | businesswire.comOmeros Shares Drop After Notes ConversionsMay 12, 2025 | marketwatch.comOmeros (OMER) Signs Debt Restructuring Deal for Convertible NotesMay 12, 2025 | gurufocus.comOmeros Corporation Announces Agreements to Acquire $80. ...May 12, 2025 | gurufocus.comOmeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026May 12, 2025 | businesswire.comOmeros (OMER) Trading Suspension Amid Volatility | OMER Stock NewsMay 12, 2025 | gurufocus.comOmeros (OMER) Resumes Trading Amid Market Developments | OMER Stock NewsMay 12, 2025 | gurufocus.comOmeros Corporation Announces Agreements to Acquire $80. ...May 12, 2025 | gurufocus.comOmeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026May 12, 2025 | businesswire.comOmeros' (OMER) "Buy" Rating Reaffirmed at D. Boral CapitalD. Boral Capital restated a "buy" rating and set a $36.00 price objective on shares of Omeros in a research note on Wednesday.May 9, 2025 | marketbeat.comAncora Advisors LLC Boosts Stake in Omeros Co. (NASDAQ:OMER)Ancora Advisors LLC grew its stake in shares of Omeros Co. (NASDAQ:OMER - Free Report) by 1,036.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 85,800 shares of the biopharmaceutical company's stock after buying an additional 78,25May 8, 2025 | marketbeat.comFDA reviews Omeros drug for stem cell transplant complicationMay 7, 2025 | investing.comFDA Accepts Omeros (OMER) Resubmission for Narsoplimab Label ExpansionMay 6, 2025 | gurufocus.comFDA Reviews Omeros' (OMER) Resubmission for Narsoplimab Approval | OMER Stock NewsMay 6, 2025 | gurufocus.comMarshall Wace LLP Invests $437,000 in Omeros Co. (NASDAQ:OMER)Marshall Wace LLP bought a new stake in shares of Omeros Co. (NASDAQ:OMER - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 44,205 shares of the biopharmaceutical company's stock, valued at approximately $437,00May 6, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Makes New $1.49 Million Investment in Omeros Co. (NASDAQ:OMER)Susquehanna Fundamental Investments LLC acquired a new position in shares of Omeros Co. (NASDAQ:OMER - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 150,557 shares of the biopharmaceuticalMay 3, 2025 | marketbeat.comOmeros Co. (NASDAQ:OMER) Shares Sold by Stifel Financial CorpStifel Financial Corp lowered its position in Omeros Co. (NASDAQ:OMER - Free Report) by 17.0% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,581,205 shares of the biopharmaceutical company's stock after selling 323,002 shares duringApril 29, 2025 | marketbeat.comOmeros Co. (NASDAQ:OMER) Receives Consensus Recommendation of "Moderate Buy" from AnalystsOmeros Co. (NASDAQ:OMER - Get Free Report) has received an average recommendation of "Moderate Buy" from the five brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has iApril 28, 2025 | marketbeat.comVanguard Group Inc. Reduces Stock Position in Omeros Co. (NASDAQ:OMER)Vanguard Group Inc. lowered its stake in shares of Omeros Co. (NASDAQ:OMER - Free Report) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,141,657 shares of the biopharmaceutical company's stApril 16, 2025 | marketbeat.comD. Boral Capital Reaffirms Buy Rating for Omeros (NASDAQ:OMER)D. Boral Capital reissued a "buy" rating and set a $36.00 target price on shares of Omeros in a research report on Friday.April 13, 2025 | marketbeat.comOmeros' New Leukemia Drug Team Ignites Hope For Cancer FightApril 11, 2025 | benzinga.comOmeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros' Proprietary OncotoX-AML Clinical ProgramApril 10, 2025 | businesswire.comOmeros (NASDAQ:OMER) Downgraded by StockNews.com to SellStockNews.com cut shares of Omeros from a "hold" rating to a "sell" rating in a report on Wednesday.April 10, 2025 | marketbeat.comOmeros FY2025 EPS Estimate Decreased by Cantor FitzgeraldOmeros Co. (NASDAQ:OMER - Free Report) - Stock analysts at Cantor Fitzgerald cut their FY2025 earnings per share (EPS) estimates for Omeros in a report released on Wednesday, April 2nd. Cantor Fitzgerald analyst O. Brayer now expects that the biopharmaceutical company will post earnings of ($2.19April 6, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Shares Up 9.2% - Time to Buy?Omeros (NASDAQ:OMER) Trading Up 9.2% - What's Next?April 4, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Upgraded to Hold at StockNews.comStockNews.com raised Omeros from a "sell" rating to a "hold" rating in a research note on Tuesday.April 3, 2025 | marketbeat.com Get Omeros News Delivered to You Automatically Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter. Email Address OMER Media Mentions By Week OMER Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OMER News Sentiment▼0.871.03▲Average Medical News Sentiment OMER News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OMER Articles This Week▼103▲OMER Articles Average Week Get Omeros News Delivered to You Automatically Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NKTR News ASMB News CPIX News LLY News JNJ News ABBV News MRK News PFE News BMY News ZTS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OMER) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omeros Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omeros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OMER Stock Free OMER Stock Alerts